TOP STORIES

• BUSINESS Top 4 Wholesalers on Recovery Trend, Operating Profit Up 69.1% in April-September
  November 16, 2022

• BUSINESS Nichi-Iko to Be Delisted, Seeks Turnaround under Medipal-JWP Joint Firm; President to Bow Out
  November 15, 2022

• REGULATORY Shionogi’s COVID Pill Up for 3rd Round of Discussion for Emergency Approval on Nov. 22
  November 15, 2022

• BUSINESS Asian Regulatory Harmonization Underutilized by Japan Drug Makers, Priorities on Western Markets
  November 14, 2022

• REGULATORY Kokando Told to Suspend Business for Up to 36 Days over Decades-Long Violations
  November 14, 2022

• REGULATORY Zero Coefficient Rule Hits All 10 Premium-Granted Drugs Priced by Cost Formula in FY2022
  November 11, 2022

• REGULATORY Skyrizi Auto-Doser Peak Sales Put at 30-Plus Billion Yen, Mounjaro Not on Roster: November Listing
  November 10, 2022

• BUSINESS Lilly CEO Sees Donanemab’s Accelerated Nod in Coming Months, Japan Approval in 2024
  November 9, 2022

• REGULATORY MOF Proposes Transition to Normal Framework for COVID Vaccines, Therapeutics
  November 8, 2022

• REGULATORY MOF Renews Its Push for Full Drug Price Revision in FY2023
  November 8, 2022

• BUSINESS Cartagena Act Stalls Gene Therapy Development in Japan; Pfizer, FIRM Calling for Deregulation
  November 7, 2022

• BUSINESS Moderna Forging Ahead with mRNA Vaccine Programs for Difficult Viruses; CMV, HIV Jabs in Pipeline: CSO
  November 4, 2022

• ORGANIZATION Priority of Japan Investment Lowered at 27% of Multinational Firms: JPMA Poll
  November 2, 2022

• BUSINESS Average Price Gap for 2023 Revision Looks to Be a Bit Lower than 7.6%: Wholesalers
  November 1, 2022

• REGULATORY Aricept’s Lewy Body Dementia Indication to Be Modified after Post-Launch Trial Miss
  October 31, 2022

• REGULATORY Ex-Bureaucrats, Academics Trade Barbs over Macroeconomic Indexing; Will MOF Allow Rise in Drug Cost?
  October 28, 2022

• ORGANIZATION Japan Needs New Forum for Top-Level Dialogue Including Global CEOs: PhRMA Chair
  October 28, 2022

• BUSINESS Cancer-Savvy New CMO Eager to Extend Astellas’ Oncology Portfolio, Bag Speedy Approval
  October 28, 2022

• REGULATORY Chuikyo to Discuss 2023 Off-Year Re-Pricing with Its Implementation as Premise: MHLW
  October 27, 2022

• REGULATORY LDP to Launch Lawmakers’ League on Medical Adhesive Patches
  October 27, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• 45
• …
• Next ›
• 最終 »